Connect with us
Type 2 diabetes is strongly linked to obesity, and early, strict control may improve outcomes for millions of patients. The SURPASS-EARLY study shows tirzepatide outperforms standard...
Molecular Health GmbH, a Heidelberg-based biotech firm, filed for insolvency on June 1st, 2026, under self-administration. An investor consortium will take over its core business, continuing...
Argentina is advancing local flu vaccine production through an agreement between Sinergium Biotech, CSL Seqirus, and PAHO, boosting regional supply across Latin America and the Caribbean....
The European Commission’s draft Biotech Law II has drawn input from alternative protein and industrial biotech firms seeking clearer rules for fermentation, cultured biomass, and precision...
AstraZeneca will present over 85 abstracts at ASCO 2026, showcasing late-stage data across multiple cancers and a rare hematological disease. Highlights include trials in liver, breast,...
The FDA approved Hepcludex (bulevirtide-gmod), the first treatment for chronic hepatitis delta virus (HDV) in adults with or without compensated cirrhosis. Clinical trials showed significantly higher...
Roche Pharma invested €57 million in Spain in 2025, running 283 clinical trials on 76 molecules with 8,584 patients and 950 researchers across 178 centers. Trials...
Asabys Partners has launched Asabys Innvierte Tech Transfer, a venture capital fund of up to €120 million focused on early-stage life sciences and deep tech companies...
Researchers at McMaster University identified the uPAR receptor as a key marker in glioblastoma tumor-initiating cells. Published in Science Translational Medicine, their study showed that targeting...
Novo Nordisk has transferred its discontinued Parkinson’s therapy to AI biotech startup Cellular Intelligence, retaining equity and milestone rights instead of making a traditional sale. The...
 |
|
 |  |
 |
|